AZ aims to ship Oxford’s COVID vaccine from September using BARDA’s $1bn
AstraZeneca says $1 billion from the US Biomedical Advanced Research and Development Authority (BARDA) will fund production of Oxford University’s SARS-CoV-2 vaccine. The Anglo-Swedish drug firm said it would begin production of the vaccine candidate – previously known as ChAdOx1 nCoV-19 and ...
GSK says the eight-year agreement with the Korean CDMO brings additional and flexible capacity to manufacture its innovative biopharmaceutical th ...
A triumvirate of deals, including the acquisition of a firm that uses the measles virus as a carrier for vaccines, sees Merck & Co. jumpstart ...
Two years after announcing plans to expand into the US, WuXi Biologics has signed a land deal allowing construction of a $60 million plant in Wor ...
House tries again to promote advanced technology for the return of pharmaceutical manufacturing to the US in post-COVID-19 era.
The new HEROE ...
Recent Tweets
-
RT @Dan5tanton: Orchard Therapeutics has ceased work on a manufacturing plant in Fremont, California, reduced investment in some th… https://t.co/h0JVi3Ice5
2 weeks ago
-
RT @Dan5tanton: Regeneron says depending on trial data it could be producing hundreds of thousands of doses of an antibody cocktail… https://t.co/36qqAVeC3J
3 weeks ago
-
RT @Dan5tanton: Free #COVID19 report available from Informa Connect, based on the responses of over 600 industry folks : The Respon… https://t.co/Lny93CsPNh
3 weeks ago
-
RT @Dan5tanton: Moderna contracts #CDMO @LonzaGroup to scale up production of mRNA vaccine against #COVID19 as it aims to move into… https://t.co/JMp0AsN1uu
3 weeks ago
Trending
Analytical
eBook: Development of Bioassays — A Report from the BEBPA's First Virtual Meeting
Manufacturing
eBook: Next-Generation Vaccines — COVID-19 Challenges, Opportunities, and Patent Questions
Upstream Processing
Industrialize Your Viral Vector Production in Adherent and Suspension Cell Cultures: Know the Pros and Cons
Analytical
Are You Missing the Bigger Picture with Your AAV Analytics? Fast, Low-Volume Subvisible Particle Analysis for Characterizing Viral Vectors